Controlling the response of carbohydrate hydrolysing enzymes (α-glycosidase and α-amylase) and pancreatic lipase is an effective approach in treating post-prandial hyperglycaemia and fats metabolism in patients affected by TD2 and obesity. The gene discussed is PNLIP; the disease is obesity disorder.